SeaStar Medical Holding Corporation (ICU) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 2.63 |
| Open | 2.72 |
| Day High | 2.85 |
| Day Low | 2.59 |
| 52-Week High | 12.6 |
| 52-Week Low | 2.07 |
| Volume | 97,890.11 |
| Average Volume | 143,707 |
| Market Cap | 7.66M |
| PE | -1.13 |
| EPS | -2.38 |
| Moving Average 50 Days | 3.97 |
| Moving Average 200 Days | 4.27 |
| Change | 0.07 |
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI
GlobeNewswire Inc.
Mar 05, 2026 1:20 PM GMT
Completion of enrollment marks a key milestone toward satisfying FDA post-approval requirementsDENVER, March 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)
GlobeNewswire Inc.
Feb 09, 2026 1:20 PM GMT
Strong survival data extending to 90 days Real-world experience shows results consistent with clinical trial data Favorable safety profile – no device-related adverse events DENVER, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporat
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference
GlobeNewswire Inc.
Jan 29, 2026 1:25 PM GMT
DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, annou